RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+42.84%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$4.69B
AUM Growth
+$4.69B
(+25%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
46.5%
Holding
101
New
13
Increased
10
Reduced
7
Closed
20
Top Buys
| 1 |
Legend Biotech
LEGN
|
$95.4M |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$65.9M |
| 3 |
Cogent Biosciences
COGT
|
$59.9M |
| 4 |
Fulcrum Therapeutics
FULC
|
$56.6M |
| 5 |
Biogen
BIIB
|
$56.2M |
Top Sells
| 1 |
Veru
VERU
|
$89.3M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$61.3M |
| 3 |
Natera
NTRA
|
$46.4M |
| 4 |
Dyne Therapeutics
DYN
|
$19.3M |
| 5 |
Guardant Health
GH
|
$19.2M |
Sector Composition
| 1 | Healthcare | 98.68% |
| 2 | Financials | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $781M | 16.67% | 7,567,900 | – | – |
|
|
2
Biogen
BIIB
$19.4B
| $250M | 5.34% | 937,549 +210,525 | +29% | +$56.2M |
|
3
Cytek Biosciences
CTKB
$527M
| $197M | 4.2% | 13,381,054 | – | – |
|
|
FMTX
4
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $180M | 3.84% | 9,011,651 | – | – |
|
5
Day One Biopharmaceuticals
DAWN
$769M
| $141M | 3.01% | 7,040,622 | – | – |
|
|
JBIO
6
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $137M | 2.92% | 8,263,982 | – | – |
|
7
Rhythm Pharmaceuticals
RYTM
$6.85B
| $134M | 2.86% | 5,471,067 +600,000 | +12% | +$14.7M |
|
8
Travere Therapeutics
TVTX
$1.56B
| $121M | 2.59% | 4,922,941 | – | – |
|
|
BLU
9
DELISTED
BELLUS Health Inc.
BLU
| $120M | 2.56% | 11,385,574 +1,155,300 | +11% | +$12.2M |
|
10
Janux Therapeutics
JANX
$1.37B
| $117M | 2.5% | 8,670,644 | – | – |
|
11
Vaxcyte
PCVX
$4B
| $110M | 2.35% | 4,581,203 | – | – |
|
|
DICE
12
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $106M | 2.25% | 5,208,911 | – | – |
|
|
IMGN
13
DELISTED
Immunogen Inc
IMGN
| $104M | 2.22% | 21,741,458 | – | – |
|
14
Nkarta
NKTX
$151M
| $103M | 2.19% | 7,805,129 | – | – |
|
15
Acumen Pharmaceuticals
ABOS
$82.4M
| $98M | 2.09% | 9,770,773 | – | – |
|
|
16
Legend Biotech
LEGN
$6.41B
| $95.4M | 2.04% | +2,338,610 | New | +$95.4M |
|
17
iTeos Therapeutics
ITOS
| $84.1M | 1.8% | 4,417,259 | – | – |
|
18
Relmada Therapeutics
RLMD
$37.2M
| $74M | 1.58% | 2,000,000 | – | – |
|
19
PepGen
PEPG
$38M
| $73.8M | 1.58% | 8,131,952 | – | – |
|
20
Geron
GERN
$893M
| $70.5M | 1.5% | 30,126,299 | – | – |
|
21
Aclaris Therapeutics
ACRS
$209M
| $69.2M | 1.48% | 4,398,453 | – | – |
|
|
THRD
22
DELISTED
Third Harmonic Bio
THRD
| $65.9M | 1.41% | +3,475,687 | New | +$65.9M |
|
23
AN2 Therapeutics
ANTX
$30.1M
| $65.6M | 1.4% | 3,773,517 +25,128 | +0.7% | +$437K |
|
24
Tyra Biosciences
TYRA
$675M
| $63.6M | 1.36% | 7,236,454 | – | – |
|
25
Wave Life Sciences
WVE
$1.53B
| $62.1M | 1.32% | 17,202,009 | – | – |
|